Found "Health Promotion": 1,013 results
[Press Release] Building Stronger Pandemic Preparedness with Infectious Disease Modelling
Nonthaburi, Thailand | November 25, 2022 – The Health Intervention and Technology Assessment Program (HITAP) announced the completion of the first Technical Workshop on Infectious Disease Modelling. Research staff from the London School of Hygiene and Tropical Medicine (LSHTM) with joint appointment
[Press Release] 5 Leading Agencies Join Forces to Promote Early Health Technology Assessment for Development of Medical and Healthcare Innovations in Thailand
On June 19, 2023, the Health Intervention and Technology Assessment Program Foundation (HITAP Foundation), in collaboration with the Saw Swee Hock School of Public Health of the National University of Singapore (NUS), organized a workshop on “Fruitful Research: How to Make Health Innovation Worthwhi
Public Health Policy Development in Thailand: Success and challenges
A concept on social determinants of health and the Ottawa Charter’s action areas for health promotion have drawn, in many countries, awareness to the health impacts resulting from a public policy. In Thailand, the issue was taken under consideration in the process of the National Health Systems Refo
Deepening a newly formalized collaboration between Kenya’s Ministry of Health and Thailand’s Ministry of Public Health
Kenya’s President, His Excellency Uhuru Kenyatta has committed his government to attaining the “Big Four” agenda on 1) Food security, 2) Affordable housing, 3) Manufacturing, and 4) affordable healthcare for all by 2022. This agenda is linked to Kenya’s Vision 2030 which sought to achieve Universal
Evaluating HITAP: 2 years on
\"First Step”, a program evaluation report, assessing HITAP’s two-year efforts and providing recommendations for further development of HITAP. This program evaluation was conducted by four external evaluators including Prof. John Cairns, Dr. Kalipso Chalkidou, Prof. Paibul Suriyawongpaisal, and Dr. Jirawat Panpiemras. Moreover, Prof. Mark Sculp
NICE International: An Overview
The UK National Institute for Health and Clinical Excellence (NICE) is the independent organisation responsible for providing national guidance on the promotion of good health and the prevention and treatment of ill health.
With an annual budget of approximately £35 million, NICE employs 250 staf
The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh (2016)
Background
Economic evaluation has been implemented to inform policy in many areas, including coverage decisions, technology pricing, and the development of clinical practice guidelines. However, there are barriers to evidence-based policy in low- and middle-income countries (LMICs) that include li
The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh
Abstract
BACKGROUND:
Economic evaluation has been implemented to inform policy in many areas, including coverage decisions, technology pricing, and the development of clinical practice guidelines. However, there are barriers to evidence-based policy in low- and middle-income countries (LMICs) th
Designing a decision frame for making health resource allocation decisions: a case study in Thailand
The abundance of various innovations in healthcare (pharmaceuticals, medical devices, interventions, individual and community health promotion and disease prevention as well as a social health policy) have been continuously used in the healthcare system, resulting in a higher demand for resources and budgets in disease prevention and healthcare. Th
Yot Teerawattananon, PhD.
Yot Teerawattananon is a Assistant Secretary General of the Foundation & Senior Researcher of the Health Intervention and Technology Assessment Program (HITAP), which is a semi-autonomous research institute of Thailand’s Ministry of Public Health. The works of HITAP have been used to inform policy decisions regarding the adoption of medicines,
10 / Page